Author Correction: Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

• Aya Sugiyama,
• Akemi Kurisu,
• Shintaro Nagashima,
• Kiyomi Hando,
• Khilola Saipova,
• Sayyora Akhmedova,
• Kanon Abe,
• Hirohito Imada,
• Md Razeen Ashraf Hussain,
• Serge Ouoba,
• Bunthen E,
• Ko Ko,
• Tomoyuki Akita,
• Shinichi Yamazaki,
• Michiya Yokozaki,
• Junko Tanaka

Affiliations

Aya Sugiyama

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Akemi Kurisu

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Shintaro Nagashima

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Kiyomi Hando

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Khilola Saipova

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Sayyora Akhmedova

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Kanon Abe

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Hirohito Imada

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Md Razeen Ashraf Hussain

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Serge Ouoba

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Bunthen E

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Ko Ko

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Tomoyuki Akita

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University

Shinichi Yamazaki

Division of Clinical Laboratory Medicine, Hiroshima University Hospital

Michiya Yokozaki

Division of Clinical Laboratory Medicine, Hiroshima University Hospital

Junko Tanaka

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University